Medication info
Mglito Tablet 10/5 mg (Empagliflozin, Linagliptin)

Mglito Tablet 10/5 mg (Empagliflozin, Linagliptin)

Prescription medicationTabletOral
Ingredient · strength
Linagliptin Micronized›5mg / 1 tabletEmpagliflozin Amorphous›10mg / 1 tablet
Manufacturer / importer
Korea Prime Pharmaceutical Co., Ltd.
Appearance
Light yellow round film-coated tablet
Packaging
30 tablets/bottle, 30 tablets/box [10 tablets/PTP x 3]
Approval status
Active

MFDS item code 202501305 · Approved 2025.05.27

Summary

Main use
Improvement of blood glucose control in patients with type 2 diabetes
Who takes it
Adults
Adult dose
The recommended starting dose of this medicine is empagliflozin 10 mg/linagliptin 5 mg once daily. If this dose is tolerated and additional glycemic control is needed, the dose may be increased to 25/5 mg once daily. Patients switching to this medicine from combination therapy with empagliflozin and linagliptin should take their existing doses. This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. However, if it is within 12 hours of your next dose, skip the missed dose and take the next dose at the usual time. Do not take a double dose in one day. Patients with renal impairment This medicine is not recommended for patients with an estimated glomerular filtration rate (eGFR) of less than 45 ml/min/1.73m2 for the purpose of improving glycemic control. No dose adjustment is needed for patients with an estimated glomerular filtration rate of 45 ml/min/1.73m2 or higher. Patients with hepatic impairment No dose adjustment is needed for patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment because it has not been studied in this population. Elderly patients No dose adjustment is needed based on age. For patients aged 75 years and older, consider renal function and the risk of volume depletion.

Ingredients

Manufacturer
Korea Prime Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of blood glucose control in patients with type 2 diabetes

View approved original text

This medication is used to help manage blood sugar levels in patients with type 2 diabetes. It is particularly effective for those who are also following dietary and exercise regimens, and helps to better manage blood sugar levels through the combined administration of empagliflozin and linagliptin. Therefore, it is used to improve blood sugar levels and assist in the management of diabetes.

How to take

Adult dose

The recommended starting dose of this medicine is empagliflozin 10 mg/linagliptin 5 mg once daily. If this dose is tolerated and additional glycemic control is needed, the dose may be increased to 25/5 mg once daily. Patients switching to this medicine from combination therapy with empagliflozin and linagliptin should take their existing doses. This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. However, if it is within 12 hours of your next dose, skip the missed dose and take the next dose at the usual time. Do not take a double dose in one day. Patients with renal impairment This medicine is not recommended for patients with an estimated glomerular filtration rate (eGFR) of less than 45 ml/min/1.73m2 for the purpose of improving glycemic control. No dose adjustment is needed for patients with an estimated glomerular filtration rate of 45 ml/min/1.73m2 or higher. Patients with hepatic impairment No dose adjustment is needed for patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment because it has not been studied in this population. Elderly patients No dose adjustment is needed based on age. For patients aged 75 years and older, consider renal function and the risk of volume depletion.

Precautions

This medication is composed of two ingredients: empagliflozin and linagliptin. It is used to help manage blood sugar levels in patients with type 2 diabetes. This medication should not be used by certain patients. For example, those with an allergy to any ingredients of this medication, type 1 diabetes patients, patients with diabetic ketoacidosis, patients undergoing dialysis, and those with a history of myocardial infarction should not take this medication. Patients with poor renal function must check their renal function before taking this medication and should also regularly monitor renal status during treatment. Moreover, caution is needed for patients with heart failure, and it is not recommended for those with severe heart failure. Serious skin conditions, such as acute pancreatitis or bullous pemphigoid, may occur while taking this medication, so patients should inform their doctor immediately if they experience severe abdominal pain or develop blisters on the skin. The most common side effect is urinary tract infection; other side effects may include hypoglycemia, thirst, cough, constipation, itching, and rash. Particularly, the risk of hypoglycemia increases when taken with insulin or sulfonylureas, so caution is necessary. This medication may lower blood pressure, hence, patients at risk of hypotension or dehydration, particularly those aged over 75 years, should take it with caution. Additionally, this medication may increase the risk of genital fungal infections; if infection symptoms arise, treatment should be sought. Pregnant or breastfeeding women should avoid taking this medication, and especially during breastfeeding, it is recommended to discontinue breastfeeding. The safety and efficacy of this medication in children have not been established, and it should not be used in patients under 18 years of age. In case of overdose, the patient should seek immediate medical attention for appropriate treatment, as the components of this medication may not be removed through blood dialysis. This medication should be stored out of reach of children, and it is safe to keep it in its original container. While taking this medication, special attention is required when driving or operating machinery due to the risk of hypoglycemia, especially if taken with insulin or sulfonylureas. Finally, patients taking this medication should have regular check-ups with their doctor and consult immediately if any abnormal symptoms occur.

Side effects

  • Urinary tract infection
  • vulvovaginitis
  • vulvitis
  • balanitis
  • other genital infections
  • hypersensitivity reactions
  • angioedema
  • urticaria
  • hypoglycemia
  • thirst
Show 114 more
  • ketoacidosis
  • cough
  • constipation
  • pancreatitis
  • oral ulcers
  • itching
  • rash
  • vesicular pemphigoid
  • rhabdomyolysis
  • decreased fluid volume
  • increased urination
  • dysuria
  • interstitial nephritis
  • increased amylase
  • increased lipase
  • increased hematocrit
  • increased serum lipids
  • increased serum creatinine
  • nasopharyngitis
  • perineal necrosis
  • upper abdominal pain
  • enterocolitis
  • bowel obstruction
  • gastroenteritis
  • shingles
  • cystitis
  • acute pyelonephritis
  • bronchitis
  • vestibular neuronitis
  • sepsis
  • pneumonia
  • decreased appetite
  • dehydration
  • hyperglycemia
  • cerebral infarction
  • stuttering
  • Alzheimer's type dementia
  • chest pain
  • fever
  • facial edema
  • fatigue
  • death
  • chronic obstructive pulmonary disease
  • asthma
  • diabetic foot disease
  • skin lesions
  • liver metastasis
  • acute leukemia
  • basal cell carcinoma
  • non-small cell lung cancer
  • malignant pericardial effusion
  • gastric cancer
  • rectal cancer
  • pancreatic cancer
  • meniscus injury
  • pneumoconiosis
  • congestive heart failure
  • angina pectoris
  • acute myocardial infarction
  • unstable angina
  • cardiac arrest
  • diabetic retinopathy
  • acute kidney injury
  • end-stage renal disease
  • acute cholangitis
  • acute cholecystitis
  • cholangitis
  • dizziness
  • kidney transplant failure
  • diarrhea
  • vomiting
  • irritable bowel syndrome
  • colitis
  • abdominal discomfort
  • dysphagia
  • gastric ulcer
  • gum bleeding
  • tooth loss
  • hemorrhoids
  • lower abdominal pain
  • alopecia areata
  • rhinitis
  • soft tissue infection
  • pharyngitis
  • scrub typhus
  • periodontitis
  • tonsillitis
  • laryngitis
  • viral upper respiratory infection
  • tonsillitis
  • hypercholesterolemia
  • inadequate diabetes control
  • malnutrition
  • hyponatremia
  • headache
  • drowsiness
  • chest discomfort
  • weakness
  • nosebleed
  • oropharyngeal pain
  • voice disturbances
  • allergic rhinitis
  • exertional dyspnea
  • wet cough
  • residual phlegm
  • epistaxis
  • otalgia
  • positional vertigo
  • lymphadenopathy
  • hypothyroidism
  • thyroid nodule
  • weight loss
  • vulvar pruritus
  • insomnia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly sealed container to prevent exposure to air or moisture. It is important to maintain a storage temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

Light yellow round film-coated tablet

Package unit

30 tablets/bottle, 30 tablets/box [10 tablets/PTP x 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.